These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11190805)

  • 1. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
    Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
    Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
    Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
    Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
    Maxwell GL; Risinger JI; Gumbs C; Shaw H; Bentley RC; Barrett JC; Berchuck A; Futreal PA
    Cancer Res; 1998 Jun; 58(12):2500-3. PubMed ID: 9635567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal analysis and mutations in the PTEN and the K-ras genes in endometrial hyperplasia.
    Sun H; Enomoto T; Shroyer KR; Ozaki K; Fujita M; Ueda Y; Nakashima R; Kuragaki C; Ueda G; Murata Y
    Diagn Mol Pathol; 2002 Dec; 11(4):204-11. PubMed ID: 12459636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
    Kanaya T; Kyo S; Sakaguchi J; Maida Y; Nakamura M; Takakura M; Hashimoto M; Mizumoto Y; Inoue M
    Am J Clin Pathol; 2005 Jul; 124(1):89-96. PubMed ID: 15923161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression.
    Salvesen HB; Stefansson I; Kretzschmar EI; Gruber P; MacDonald ND; Ryan A; Jacobs IJ; Akslen LA; Das S
    Int J Oncol; 2004 Dec; 25(6):1615-23. PubMed ID: 15547698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: a population-based study from northern Norway with long-term follow-up.
    Orbo A; Kaino T; Arnes M; Kopp M; Eklo K
    Gynecol Oncol; 2004 Oct; 95(1):82-8. PubMed ID: 15385114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas.
    Minaguchi T; Yoshikawa H; Oda K; Ishino T; Yasugi T; Onda T; Nakagawa S; Matsumoto K; Kawana K; Taketani Y
    Clin Cancer Res; 2001 Sep; 7(9):2636-42. PubMed ID: 11555573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN sequence analysis in endometrial hyperplasia and endometrial carcinoma in Slovak women.
    Gbelcová H; Bakeš P; Priščáková P; Šišovský V; Hojsíková I; Straka Ľ; Konečný M; Markus J; D'Acunto CW; Ruml T; Böhmer D; Danihel Ľ; Repiská V
    Anal Cell Pathol (Amst); 2015; 2015():746856. PubMed ID: 26114084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases.
    Bussaglia E; del Rio E; Matias-Guiu X; Prat J
    Hum Pathol; 2000 Mar; 31(3):312-7. PubMed ID: 10746673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of endometrial hyperplasia and carcinoma.
    Matias-Guiu X; Catasus L; Bussaglia E; Lagarda H; Garcia A; Pons C; Muñoz J; Argüelles R; Machin P; Prat J
    Hum Pathol; 2001 Jun; 32(6):569-77. PubMed ID: 11431710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
    Konopka B; Janiec-Jankowska A; Kwiatkowska E; Najmoła U; Bidziński M; Olszewski W; Goluda C
    Hum Pathol; 2011 Nov; 42(11):1710-9. PubMed ID: 21531001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
    Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
    Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
    Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutation of PTEN in vulvar cancer.
    Holway AH; Rieger-Christ KM; Miner WR; Cain JW; Dugan JM; Pezza JA; Silverman ML; Shapter A; McLellan R; Summerhayes IC
    Clin Cancer Res; 2000 Aug; 6(8):3228-35. PubMed ID: 10955808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability.
    Cohn DE; Basil JB; Venegoni AR; Mutch DG; Rader JS; Herzog TJ; Gersell DJ; Goodfellow PJ
    Gynecol Oncol; 2000 Oct; 79(1):101-6. PubMed ID: 11006040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
    Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
    Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.
    Risinger JI; Hayes K; Maxwell GL; Carney ME; Dodge RK; Barrett JC; Berchuck A
    Clin Cancer Res; 1998 Dec; 4(12):3005-10. PubMed ID: 9865913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of germline PTEN mutations in endometrial cancer patients.
    Black D; Bogomolniy F; Robson ME; Offit K; Barakat RR; Boyd J
    Gynecol Oncol; 2005 Jan; 96(1):21-4. PubMed ID: 15589575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.